Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 68.03%718.58M | 89.70%482.72M | 126.90%252.99M | 1.41%649.37M | -17.57%427.64M | -34.72%254.47M | -53.41%111.5M | 3.89%640.32M | 13.28%518.81M | 38.07%389.83M |
| Operating revenue | 68.03%718.58M | 89.70%482.72M | 126.90%252.99M | 1.41%649.37M | -17.57%427.64M | -34.72%254.47M | -53.41%111.5M | 3.89%640.32M | 13.28%518.81M | 38.07%389.83M |
| Total operating cost | 81.69%608.09M | 98.08%402.17M | 117.31%204.36M | 5.42%499.73M | -10.48%334.69M | -28.54%203.03M | -46.89%94.04M | 6.60%474.06M | 14.89%373.87M | 40.86%284.13M |
| Operating cost | 84.78%498.66M | 104.34%331.97M | 123.87%169.68M | 2.70%404.54M | -14.34%269.86M | -33.62%162.46M | -52.11%75.8M | 6.29%393.91M | 14.92%315.02M | 45.13%244.72M |
| Operating tax surcharges | 103.45%9.85M | 140.81%6.72M | 202.15%4.03M | 26.38%7.01M | -3.97%4.84M | -8.50%2.79M | -19.42%1.33M | -28.03%5.54M | 15.46%5.04M | 4.25%3.05M |
| Operating expense | 24.99%14.15M | 17.99%9.36M | 73.57%4.83M | 28.18%14.98M | 0.16%11.32M | -0.51%7.94M | -38.21%2.78M | -6.96%11.68M | 22.20%11.3M | 42.56%7.98M |
| Administration expense | 51.10%44.64M | 46.01%28.42M | 53.47%13.81M | 25.40%42.03M | 21.37%29.55M | 19.84%19.47M | 21.00%9M | 14.88%33.52M | 22.19%24.34M | 32.54%16.24M |
| Financial expense | 151.30%3.33M | 150.79%2.01M | 144.28%749.52K | 9.37%-8.35M | 15.99%-6.49M | 19.35%-3.95M | 9.72%-1.69M | -59.76%-9.21M | -117.73%-7.72M | -189.92%-4.9M |
| -Interest expense (Financial expense) | 896.86%6.65M | 836.43%4.74M | 856.23%2.4M | 3.67%799.55K | 486.47%667.57K | 359.15%506.34K | 111.27%250.66K | 121.72%771.23K | 17.08%113.83K | 48.37%110.28K |
| -Interest Income (Financial expense) | 39.60%-2.97M | 27.25%-2.38M | 18.20%-1.39M | 37.73%-6.77M | 45.63%-4.92M | 48.74%-3.28M | 50.63%-1.7M | -92.65%-10.87M | -238.92%-9.04M | -308.16%-6.39M |
| Research and development | 46.27%37.46M | 65.25%23.69M | 65.09%11.26M | 2.36%39.53M | -1.07%25.61M | -15.88%14.34M | -3.88%6.82M | 26.87%38.61M | 21.51%25.88M | 21.71%17.04M |
| Credit Impairment Loss | -63.25%-385.5K | -85.57%-438.21K | ---583.39K | -22.85%-244.78K | -58.18%-236.14K | -58.18%-236.14K | ---- | -229.63%-199.26K | -452.85%-149.29K | -452.85%-149.29K |
| Asset Impairment Loss | ---2.54M | ---2.54M | ---- | -65.78%-4.3M | ---- | ---- | ---- | -153.75%-2.59M | ---- | ---- |
| Other net revenue | ||||||||||
| Asset deal income | ---- | ---- | ---- | --2.78K | --2.78K | ---- | ---- | ---- | ---- | ---- |
| Other revenue | 10.60%6.18M | -18.94%4.41M | -19.04%2.55M | -25.61%7.53M | -55.74%5.59M | -30.55%5.44M | 436.25%3.15M | -44.29%10.12M | -27.82%12.63M | 111.24%7.84M |
| Operating profit | 15.70%113.75M | 44.73%81.98M | 145.46%50.6M | -12.08%152.63M | -37.55%98.31M | -50.04%56.64M | -67.20%20.61M | -13.42%173.6M | -1.58%157.42M | 25.11%113.38M |
| Add:Non operating Income | 364,581.91%2.19M | 755,711.97%1.51M | --1.51M | 46.12%697.71K | -98.52%600 | -98.61%200 | ---- | 1,125.32%477.48K | --40.47K | --14.4K |
| Less:Non operating expense | 3,237.26%1.88M | 4,876.17%1.81M | -62.54%13.64K | -61.38%68.35K | -3.67%56.41K | -18.23%36.41K | -18.19%36.41K | -91.76%176.97K | -96.23%58.56K | -97.13%44.53K |
| Total profit | 16.08%114.05M | 44.29%81.68M | 153.15%52.09M | -11.87%153.26M | -37.58%98.26M | -50.06%56.61M | -67.24%20.58M | -12.35%173.9M | -0.63%157.4M | 27.26%113.35M |
| Less:Income tax cost | 34.57%18.61M | 68.29%13.68M | 172.49%8.14M | 10.35%18.21M | -42.11%13.83M | -54.44%8.13M | -69.14%2.99M | -38.66%16.51M | -1.15%23.88M | 29.66%17.84M |
| Net profit | 13.05%95.44M | 40.27%68M | 149.86%43.95M | -14.20%135.05M | -36.77%84.43M | -49.24%48.48M | -66.90%17.59M | -8.22%157.39M | -0.54%133.52M | 26.82%95.51M |
| Net profit from continuing operation | 13.05%95.44M | 40.27%68M | 149.86%43.95M | -14.20%135.05M | -36.77%84.43M | -49.24%48.48M | -66.90%17.59M | -8.22%157.39M | -0.54%133.52M | 26.82%95.51M |
| Less:Minority Profit | -17.59%2.41M | 10.56%1.52M | 1,189.41%547.33K | 28.57%4.85M | 189.67%2.93M | 1,506.82%1.38M | 105.76%42.45K | 3,070.96%3.77M | --1.01M | --85.66K |
| Net profit of parent company owners | 14.15%93.03M | 41.13%66.48M | 147.35%43.4M | -15.25%130.2M | -38.49%81.5M | -50.64%47.1M | -67.43%17.55M | -10.36%153.62M | -1.29%132.51M | 26.71%95.42M |
| Earning per share | ||||||||||
| Basic earning per share | 13.89%0.41 | 42.86%0.3 | 137.50%0.19 | -14.71%0.58 | -38.98%0.36 | -50.00%0.21 | -66.67%0.08 | -10.53%0.68 | -1.67%0.59 | 23.53%0.42 |
| Diluted earning per share | 13.89%0.41 | 42.86%0.3 | 137.50%0.19 | -14.71%0.58 | -38.98%0.36 | -50.00%0.21 | -66.67%0.08 | -10.53%0.68 | -1.67%0.59 | 23.53%0.42 |
| Other composite income | ||||||||||
| Total composite income | 13.05%95.44M | 40.27%68M | 149.86%43.95M | -14.20%135.05M | -36.77%84.43M | -49.24%48.48M | -66.90%17.59M | -8.22%157.39M | -0.54%133.52M | 26.82%95.51M |
| Total composite income of parent company owners | 14.15%93.03M | 41.13%66.48M | 147.35%43.4M | -15.25%130.2M | -38.49%81.5M | -50.64%47.1M | -67.43%17.55M | -10.36%153.62M | -1.29%132.51M | 26.71%95.42M |
| Total composite income of minority owners | -17.59%2.41M | 10.56%1.52M | 1,189.41%547.33K | 28.57%4.85M | 189.67%2.93M | 1,506.82%1.38M | 105.76%42.45K | 3,070.96%3.77M | --1.01M | --85.66K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | -- | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.